We have located links that may give you full text access.
A tactile pain evaluation scale for visually deficient persons.
Pain Medicine 2023 Februrary 22
OBJECTIVE: Pain evaluation scales often rely on the sense of sight. There is so far no pain assessment scale specifically designed for persons with visual impairment.
DESIGN: This study aims to validate a tactile pain evaluation scale, Visiodol©, in blind/visually impaired persons, by correlation with a numeric pain scale (NPS).
SETTING: The study took place in University Hospital Clermont-Fd, France.
METHODS: Pain intensity for a range of thermal stimuli (Pathway Medoc®) was evaluated with Visiodol© and NPS; secondary outcomes including pain thresholds, catastrophizing, emotion and quality of life were compared in blind/visually impaired and sighted persons. Lin's concordance correlation coefficient was estimated; weighted Cohen κ accounted for degrees of disagreement between scales with 95% confidence interval (95%CI).
SUBJECTS: 21 healthy sighted and 21 healthy non-sighted volunteers (n = 13 congenital, n = 8 acquired) were included.
RESULTS: Lin's correlation coefficient for repeated data was 0.967 (95%CI, 0.956; 0.978; P < 0.001) for visually impaired participants with a good agreement at each temperature plateau. Weighted Cohen κ of 0.90 (95% CI, 0.84-0.92) and 92.9% percentage of agreement for visually impaired participants was satisfactory. Pain perception, psychological components and quality of life were more impaired in blind/visually impaired persons than in sighted persons.
CONCLUSIONS: This study validates Visiodol©, a tactile scale for blind/visually impaired persons and addresses healthcare inequalities in the context of pain evaluation. It will now be tested on a larger population of patients in order to give the millions of blind/visually impaired persons worldwide, an option for pain intensity evaluation in clinical situations.
DESIGN: This study aims to validate a tactile pain evaluation scale, Visiodol©, in blind/visually impaired persons, by correlation with a numeric pain scale (NPS).
SETTING: The study took place in University Hospital Clermont-Fd, France.
METHODS: Pain intensity for a range of thermal stimuli (Pathway Medoc®) was evaluated with Visiodol© and NPS; secondary outcomes including pain thresholds, catastrophizing, emotion and quality of life were compared in blind/visually impaired and sighted persons. Lin's concordance correlation coefficient was estimated; weighted Cohen κ accounted for degrees of disagreement between scales with 95% confidence interval (95%CI).
SUBJECTS: 21 healthy sighted and 21 healthy non-sighted volunteers (n = 13 congenital, n = 8 acquired) were included.
RESULTS: Lin's correlation coefficient for repeated data was 0.967 (95%CI, 0.956; 0.978; P < 0.001) for visually impaired participants with a good agreement at each temperature plateau. Weighted Cohen κ of 0.90 (95% CI, 0.84-0.92) and 92.9% percentage of agreement for visually impaired participants was satisfactory. Pain perception, psychological components and quality of life were more impaired in blind/visually impaired persons than in sighted persons.
CONCLUSIONS: This study validates Visiodol©, a tactile scale for blind/visually impaired persons and addresses healthcare inequalities in the context of pain evaluation. It will now be tested on a larger population of patients in order to give the millions of blind/visually impaired persons worldwide, an option for pain intensity evaluation in clinical situations.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app